Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-08-012018
Filing Date
2008-10-03
Accepted
2008-10-03 17:21:15
Documents
5
Period of Report
2008-11-09
Effectiveness Date
2008-10-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT y00215def14a.htm DEF 14A 379947
2 GRAPHIC y00215y0021500.gif GRAPHIC 1536
3 GRAPHIC y00215y0021501.gif GRAPHIC 32921
4 GRAPHIC y00215y0021502.gif GRAPHIC 57414
5 GRAPHIC y00215y0021503.gif GRAPHIC 89247
  Complete submission text file 0000950123-08-012018.txt   631789
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 081107500
SIC: 2836 Biological Products, (No Diagnostic Substances)